All In Biotech

Drug Trial Radar · NCT05748600

A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Eosinophilic Asthma

A Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Assess the Efficacy, Safety, and Tolerability of Dexpramipexole Administered Orally for 24 Weeks in Participants With Eosinophilic Asthma

Last checked: Nov 19, 2026Latest source record: Sep 5, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. Randomized with 600 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

600

Planned (sponsor's estimate)

Start

Jan 30, 2023

Primary completion

Sep 2025

Study completion Dec 2025

Sponsor

Lead sponsor
Areteia TherapeuticsIndustry
Sponsor type
Industry
First posted
Feb 28, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 12 years, up to 99 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate dexpramipexole as an add-on oral therapy in participants with inadequately controlled eosinophilic asthma to evaluate improvements in lung function, asthma control, and quality of life. In addition, the study will further evaluate the safety and tolerability of dexpramipexole in participants with eosinophilic asthma.

Conditions

  • Eosinophilic Asthma
  • Asthma; Eosinophilic
  • Asthma Attack

Interventions

  • Dexpramipexole DihydrochlorideDrug

    administration of dexpramipexole tablet

  • PlaceboDrug

    administration of placebo tablet

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in pre-BD FEV₁ from baselineTime frame: Day 1 (baseline, pre-dose), Weeks 20, 24

Locations

335 sites in 18 countries. Site status is shown where the registry gives one.

  • Research Site 40001-487

    Chandler, Arizona

  • Research Site 40001-462

    Peoria, Arizona

  • Research Site 40001-322

    Surprise, Arizona

  • Research Site 40001-374

    Bakersfield, California

  • Research Site 40001-227

    Encinitas, California

  • Research Site 40001-349

    Huntington Beach, California

  • Research Site 40001-485

    Inglewood, California

  • Research Site 40001-440

    La Palma, California

  • Research Site 40001-357

    Lancaster, California

  • Research Site 40001-089

    Los Angeles, California

  • Research Site 40001-362

    Mission Viejo, California

  • Research Site 40001-449

    Napa, California

  • Research Site 40001-062

    Newport Beach, California

  • Research Site 40001-043

    Newport Beach, California

  • Research Site 40001-380

    Redding, California

  • Research Site 40001-434

    San Diego, California

  • Research Site 40001-088

    San Jose, California

  • Research Site 40001-359

    Upland, California

  • Research Site 40001-003

    West Covina, California

  • Research Site 40001-419

    Westminster, California

  • Research Site 40001-425

    Aurora, Colorado

  • Research Site 40001-353

    Colorado Springs, Colorado

  • Research Site 40001-385

    Wheat Ridge, Colorado

  • Research Site 40001-048

    Aventura, Florida

  • Research Site 40001-005

    Brandon, Florida

  • Research Site 40001-051

    Brandon, Florida

  • Research Site 40001-029

    Coral Gables, Florida

  • Research Site 40001-350

    Gainesville, Florida

  • Research Site 40001-014

    Greenacres City, Florida

  • Research Site 40001-054

    Hialeah, Florida

  • Research Site 40001-067

    Hialeah, Florida

  • Research Site 40001-020

    Homestead, Florida

  • Research Site 40001-015

    Kissimmee, Florida

  • Research Site 40001-002

    Kissimmee, Florida

  • Research Site 40001-086

    Loxahatchee Groves, Florida

  • Research Site 40001-318

    Maitland, Florida

  • Research Site 40001-066

    Miami, Florida

  • Research Site 40001-001

    Miami, Florida

  • Research Site 40001-059

    Miami, Florida

  • Research Site 40001-026

    Miami, Florida

Showing 40 of 335 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.